SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla zooms after doubling Remdesivir production to meet 'unprecedented' demand

15 Apr 2021 Evaluate

Cipla is currently trading at Rs. 918.85, up by 33.65 points or 3.80% from its previous closing of Rs. 885.20 on the BSE.

The scrip opened at Rs. 900.00 and has touched a high and low of Rs. 925.15 and Rs. 882.60 respectively. So far 306240 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 940.00 on 12-Apr-2021 and a 52 week low of Rs. 565.90 on 15-May-2020.

Last one week high and low of the scrip stood at Rs. 940.00 and Rs. 836.75 respectively. The current market cap of the company is Rs. 74319.62 crore.

The promoters holding in the company stood at 36.70%, while Institutions and Non-Institutions held 40.05% and 23.25% respectively.

Cipla has doubled production of COVID-19 medication remdesivir to help meet ‘unprecedented demand’ as the country battles a massive second wave of infections. India has overtaken Brazil as the world’s second-worst coronavirus-hit country after the United States, having administered about 107 million vaccine doses among a population of 1.4 billion.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1316.50 -31.20 (-2.32%)
11-May-2026 12:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.90
Dr. Reddys Lab 1294.65
Cipla 1316.50
Zydus Lifesciences 943.40
Lupin 2256.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×